Floating-Harbor syndrome ‒ case report with literature review
DOI:
https://doi.org/10.15584/ejcem.2026.1.25Keywords:
Floating-Harbor syndrome, short stature, recombinant human growth hormone treatmentAbstract
Introduction and aim. Floating-Harbor syndrome (FHS) is a very rare disease, whose typical characteristics include short stature, facial dysmorphic features and significant speech delay. We aim to present the first reported case of FHS with discordant growth hormone tests and confirmed hypoplasia of the pituitary gland.
Description of the case. We report a case of a boy aged 8 years and 3 months with a height constantly below the 3rd percentile, delayed bone age in comparison to chronological age, typical dysmorphic triangular face and a high-pitched voice. Whole-exome sequencing (WES) detected a heterozygous pathogenic variant in SRCAP gene – a confirmation of the diagnosis Floating-Harbor syndrome (FHS). Recombinant human growth hormone (rhGH) therapy at a dose of 0.033 mg/kg/day (0.65 mg/day) was initiated at the age of 7 years and 10 months. Because of the insufficient growth velocity at the time of manuscript preparation a dose increase was made to 0.035 mg/kg/day (0.80 mg/day).
Conclusion. In children presenting with short stature (especially when GH deficiency is confirmed), facial dysmorphism and developmental delay, Floating-Harbor syndrome should be considered as a possible diagnosis. A multidisciplinary approach involving pediatric endocrinologists, geneticists and developmental specialists is essential for timely etiological diagnosis and optimal management.
Downloads
References
Patton MA, Hurst J, Donnai D, McKeown CM, Cole T, Goodship J. Floating-Harbor syndrome. J Med Genet. 1991;28(3):201. doi:10.1136/jmg.28.3.201
Turkunova ME, Barbitoff YA, Serebryakova EA, et al. Molecular Genetics and Pathogenesis of the Floating Harbor Syndrome: Case Report of Long-Term Growth Hormone Treatment and a Literature Review. Front Genet. 2022;13:846101. doi:10.3389/fgene.2022.846101
Lacombe D, Patton MA, Elleau C, Battin J. Floating-Harbor syndrome: description of a further patient, review of the literature, and suggestion of autosomal dominant inheritance. Eur J Pediatr. 1995;154(8):658-661. doi:10.1007/BF02079072
Nikkel SM, Dauber A, De Munnik S, et al. The phenotype of Floating-Harbor syndrome: clinical characterization of 52 individuals with mutations in exon 34 of SRCAP. Orphanet J Rare Dis. 2013;8:63. doi:10.1186/1750-1172-8-63
Wieczorek D, Wüsthof A, Harms E, Meinecke P. Floating-Harbor syndrome in two unrelated girls: mild short stature in one patient and effective growth hormone therapy in the other. Am J Med Genet. 2001;104(1):47-52. doi:10.1002/ajmg.1585
Cannavò S, Bartolone L, Lapa D, et al. Abnormalities of GH secretion in a young girl with Floating-Harbor syndrome. J Endocrinol Invest. 2002;25(1):58-64. doi:10.1007/BF03343962
Stagi S, Galluzzi F, Bindi G, et al. Precocious puberty in a girl with Floating-Harbor syndrome. J Pediatr Endocrinol Metab. 2007;20(12):1333-1338. doi:10.1515/JPEM.2007.20.12.1333
White SM, Morgan A, Da Costa A, et al. The phenotype of Floating¬-Harbor syndrome in 10 patients. Am J Med Genet A. 2010;152(4):821-829. doi:10.1002/ajmg.a.33294
Galli-Tsinopoulou A, Kyrgios I, Emmanouilidou E, et al. Growth hormone deficiency: an unusual presentation of Floating-Harbor syndrome. Hormones (Athens). 2011;10(3):236-240. doi:10.14310/horm.2002.1314
García RJ, Kant SG, Wit JM, Mericq V. Clinical and genetic characteristics and effects of long-term growth hormone therapy in a girl with Floating-Harbor syndrome. J Pediatr Endocrinol Metab. 2012;25(1-2):207-212. doi:10.1515/jpem.2011.406
Seifert W, Meinecke P, Krüger G, et al. Expanded spectrum of exon 33 and 34 mutations in SRCAP and follow-up in patients with Floating-Harbor syndrome. BMC Med Genet. 2014;15:127. doi:10.1186/s12881-014-0127-0
Nagasaki K, Asami T, Sato H, et al. Long-term follow-up study for a patient with Floating-Harbor syndrome due to a hotspot SRCAP mutation. Am J Med Genet A. 2014;164(3):731-735. doi:10.1002/ajmg.a.36314
Zhang S, Chen S, Qin H, et al. Novel genotypes and phenotypes among Chinese patients with Floating-Harbor syndrome. Orphanet J Rare Dis. 2019;14(1):144. doi:10.1186/s13023-019-1111-8
Homma TK, Freire BL, Honjo R, et al. Growth and clinical characteristics of children with Floating-Harbor syndrome: analysis of current original data and a review of the literature. Horm Res Paediatr. 2020;92(2):115-123. doi: 10.1159/000503782
Son HW, Lee JE, Oh SH, Keum C, Chung WY. Effects of long-term growth hormone therapy in a girl with Floating-Harbor syndrome. Ann Pediatr Endocrinol Metab. 2020;25(2):126-131. doi:10.6065/apem.1938144.072
Bo H, Jiang L, Zheng J, Sun J. Floating-Harbor Syndrome treated with recombinant human growth hormone: a case report and literature review. Front Pediatr. 2021;9:747353. doi:10.3389/fped.2021.747353
Prosvirnina A, Bolmasova A, Melikyan M. A case of a Floating-Harbor syndrome in a child with severe short stature. Horm Res Paediatr. 2021;94(1):343.
Yang YC, Tang Q, Yan LJ, et al. A case of Floating-Harbor Syndrome with “growth and language development delay” as its clinical manifestation. Pharmacogenomics Pers Med. 2023;16:1091-1096. doi:10.2147/PGPM.S433444
Jeon J, Noh ES, Hwang IT. Floating-Harbor Syndrome in a Korean patient with short stature and early puberty: a case report. J Clin Res Pediatr Endocrinol. 2024. doi:10.4274/jcrpe.galenos.2024.2023-12-12
He Q, Deng Y, Xu L, et al. Recombinant human growth hormone treatment of Floating-Harbor syndrome: a case report and literature review. BMC Pediatr. 2025;25:97. doi:10.1186/s12887-025-05437-7
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 European Journal of Clinical and Experimental Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.
All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.
